Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupentixol and melitracen for refractory cough
ChiCTR2000035304Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of flupentixol and melitracen in chronic cough (2 arms), sponsored by Tongji Hospital. Primary endpoint: Treatment success rate. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
flupentixolmelitracen
03
Conditions
chronic cough
Beyond the preview
Go deeper on ChiCTR2000035304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035304.